Pfizer MVC 150 (Selzentry 150 mg)

Generic Name: maraviroc

Pill imprint Pfizer MVC 150 has been identified as Selzentry 150 mg.

Selzentry is used in the treatment of hiv infection and belongs to the drug class chemokine receptor antagonist. There is no proven risk in humans during pregnancy. Selzentry 150 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for Pfizer MVC 150

Selzentry 150 mg Pfizer MVC 150
Selzentry 150 mg Pfizer MVC 150
Selzentry
Generic Name:
maraviroc
Imprint:
Pfizer
MVC 150
Strength:
150 mg
Color:
Blue
Size:
12.00 mm
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Chemokine receptor antagonist
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Pfizer U.S. Pharmaceuticals Group
National Drug Code (NDC):
00069-0807
Inactive Ingredients:
microcrystalline cellulose
calcium phosphate dibasic anhydrous
sodium starch glycolate type A potato
magnesium stearate
FD&C Blue No. 2
aluminum oxide
soya lecithin
polyethylene glycol
polyvinyl alcohol
magnesium silicate
titanium dioxide
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
35356-0208 Lake Erie Medical and Surgical Supply (repackager)
54569-6143 A S Medication Solutions LLC (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web3)